FDA NDC Directory · JSON-LD · Markdown

LANOXIN

NDC 70515-261 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namedigoxin
Labeler / ManufacturerCovis Pharma US, Inc
Marketing categoryNew Drug Application (innovator) · App NDA009330
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsDIGOXIN (250 ug/mL)
Marketing started20191029
Package count1

External sources

Source: openFDA. Public-domain (CC0).